1H-Pyrazolo[4,3-c]pyridine-6-carboxylic acid, 95.0%, 25mg

[1-[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-4-iodobenzene](difluoroborane)>98.0%(HPLC)1g

TERT-BUTYL (2-IODO-6-METHYLPHENYL)CARBAMATE, 95.0%, 1g

(6-FLUORO-1H-INDOL-2-YL)METHANOL, 95%, 5g

tert-Butyl (4-(4-amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate, 95%, 100mg

ETHYL 3-BROMOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBOXYLATE, 95.0%, 250mg

3-Bromo-1H-pyrrole-2,5-dione, 97%, 10g

2-(2,2,2-Trifluoroacetamido)isonicotinic acid, 98%, 250mg

2,2,3-Tribromopropanal, 92.0%, 1g

GC capillary column ROTI®Cap-5 HT, 15 m, 0.32 mm, 0.25 µm, 1 Piece(s)

N-methyl-2-(4-methylpiperidin-1-yl)ethanamine, 95.0%, 1g

N-Boc-2-amino-4-thiazolacetic acid, 95.0%, 1g

4,4'-Diiodo-2,2'-dimethylbiphenyl>98.0%(GC)1g